Menopause Society Practice Exam

Screening guidelines in menopausal-age women focus on cancers with established population-wide screening programs. The best choice reflects cancers that have clear, widely recommended screening for women in this age range: breast cancer and cervical cancer.

For breast cancer, routine mammography is recommended for average-risk women starting in midlife, with regular intervals continuing through the menopausal years and beyond in most guidelines. This makes breast cancer screening highly relevant to women going through menopause.

Cervical cancer screening, typically with a Pap test and sometimes HPV testing, is recommended for most women from early adulthood through a defined age limit (often into the mid-60s). Menopausal women are squarely within this screening window, making it applicable and important.

The other options include cancers that aren’t part of universal screening for the general female population: prostate cancer is male-specific, and pancreatic cancer, ovarian cancer, and brain cancer do not have routine population-wide screening programs. Lung cancer screening exists but is targeted to a high-risk subset (older individuals with substantial smoking history), so it isn’t universally relevant to all menopausal women.